Protection Of Rat Skeletal Muscle Fibers By Either L-carnitine Or Coenzyme Q10 Against Statins Toxicity Mediated By Mitochondrial Reactive Oxygen Generation

Mitochondrial redox imbalance has been implicated in mechanisms of aging, various degenerative diseases and drug-induced toxicity. Statins are safe and well-tolerated therapeutic drugs that occasionally induce myotoxicity such as myopathy and rhabdomyolysis. Previous studies indicate that myotoxicity caused by statins may be linked to impairment of mitochondrial functions. Here, we report that 1-h incubation of permeabilized rat soleus muscle fiber biopsies with increasing concentrations of simvastatin (1-40 μM) slowed the rates of ADP-or FCCP-stimulated respiration supported by glutamate/malate in a dose-dependent manner, but caused no changes in resting respiration rates. Simvastatin (1 μM) also inhibited the ADP-stimulated mitochondrial respiration supported by succinate by 24% but not by TMPD/ascorbate. Compatible with inhibition of respiration, 1 μM simvastatin stimulated lactate release from soleus muscle samples by 26%. Co-incubation of muscle samples with 1 mM L-carnitine, 100 μM mevalonate or 10 μM coenzyme Q10 (Co-Q10) abolished simvastatin effects on both mitochondrial glutamate/malate-supported respiration and lactate release. Simvastatin (1 μM) also caused a 2-fold increase in the rate of hydrogen peroxide generation and a decrease in Co-Q10 content by 44%. Mevalonate, Co-Q10 or L-carnitine protected against stimulation of hydrogen peroxide generation but only mevalonate prevented the decrease in Co-Q10 content. Thus, independently of Co-Q10 levels, L-carnitine prevented the toxic effects of simvastatin. This suggests that mitochondrial respiratory dysfunction induced by simvastatin, is associated with increased generation of superoxide, at the levels of complexes-I and II of the respiratory chain. In all cases the damage to these complexes, presumably at the level of 4Fe-4S clusters, is prevented by L-carnitine. © 2013 La Guardia, Alberici, Ravagnani, Catharino and Vercesi.4 MAYAnderson, E.J., Neufer, P.D., Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation (2006) Am. J. Physiol. Cell Physiol., 290, pp. C844-C851Arduini, A., Peschechera, A., Giannessi, F., Carminati, P., Improvement of statin-associated myotoxicity by L-carnitine (2004) J. Thromb. Haemost., 2, pp. 2270-2271Benati, D., Ferro, M., Savino, M.T., Ulivieri, C., Schiavo, E., Nuccitelli, A., Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus (2010) J. Leukoc. Biol., 87, pp. 433-442Binienda, Z.K., Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction (2003) Ann. N. Y. Acad. Sci., 993, pp. 289-295. , discussion: 345-349Binienda, Z., Przybyla-Zawislak, B., Virmani, A., Schmued, L., L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction (2005) Ann. N. Y. Acad. Sci., 1053, pp. 174-182Bookstaver, D.A., Burkhalter, N.A., Hatzigeorgiou, C., Effect of coenzyme Q10 supplementation on statin-induced myalgias (2012) Am. J. Cardiol., 110, pp. 526-529Bouitbir, J., Charles, A.L., Echaniz-Laguna, A., Kindo, M., Daussin, F., Auwerx, J., Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1 (2012) Eur. Heart J., 33, pp. 1397-1407Bouitbir, J., Daussin, F., Charles, A.L., Rasseneur, L., Dufour, S., Richard, R., Mitochondria of trained skeletal muscle are protected from deleterious effects of statins (2012) Muscle Nerve, 46, pp. 367-373Bouton, C., Raveau, M., Drapier, J.C., Modulation of iron regulatory protein functions (1996) Further insights into the role of nitrogen- and oxygen-derived reactive species. J. Biol. Chem., 271, pp. 2300-2306Bruckert, E., Hayem, G., Dejager, S., Yau, C., Begaud, B., Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients-the PRIMO study (2005) Cardiovasc. Drugs Ther., 19, pp. 403-414Castilho, R.F., Kowaltowski, A.J., Meinicke, A.R., Vercesi, A.E., Oxidative damage of mitochondria induced by Fe(II)citrate or t-butyl hydroperoxide in the presence of Ca2+: effect of coenzyme Q redox state (1995) Free Radic. Biol. Med., 18, pp. 55-59Chariot, P., Monnet, I., Mouchet, M., Rohr, M., Lefaucheur, J.P., Dubreuil-Lemaire, M.L., Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy (1994) Arthritis Rheum, 37, pp. 583-586Costa, R.A.P., Fernandes, M.P., Souza-Pinto, N.C.D., Vercesi, A.E., Protective effects of L-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin (2013) Eur. J. Pharmacol., 701, pp. 82-86Deichmann, R., Lavie, C., Andrews, S., Coenzyme q10 and statin-induced mitochondrial dysfunction (2010) Ochsner J, 10, pp. 16-21Demicheli, V., Quijano, C., Alvarez, B., Radi, R., Inactivation and nitration of human superoxide dismutase (SOD) by fluxes of nitric oxide and superoxide (2007) Free Radic. Biol. Med., 42, pp. 1359-1368De Pinieux, G., Chariot, P., Ammi-Said, M., Louarn, F., Lejonc, J.L., Astier, A., Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio (1996) Br. J. Clin. Pharmacol., 42, pp. 333-337Elinos-Calderon, D., Robledo-Arratia, Y., Perez-De La Cruz, V., Pedraza-Chaverri, J., Ali, S.F., Santamaria, A., Early nerve ending rescue from oxidative damage and energy failure by L: - carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities. Exp (2009) Brain Res, 197, pp. 287-296Endo, A., The discovery and development of HMG-CoA reductase inhibitors (1992) J. Lipid Res., 33, pp. 1569-1582Figueira, T.R., Barros, M.H., Camargo, A.A., Castilho, R.F., Ferreira, J.C., Kowaltowski, A.J., Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health (2013) Antioxid. Redox Signal., 18, pp. 2029-2074Flint, D.H., Tuminello, J.F., Emptage, M.H., The inactivation of Fe-S cluster containing hydro-lyases by superoxide (1993) J. Biol. Chem., 268, pp. 22369-22376Fridovich, I., Superoxide radical and superoxide dismutases (1995) Annu. Rev. Biochem., 64, pp. 97-112Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study (1993) J. Clin. Pharmacol., 33, pp. 226-229Graham, D., Huynh, N.N., Hamilton, C.A., Beattie, E., Smith, R.A., Cocheme, H.M., Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy (2009) Hypertension, 54, pp. 322-328Grijalba, M.T., Vercesi, A.E., Schreier, S., Ca2+-induced increased lipid packing and domain formation in submitochondrial particles (1999) A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry, 38, pp. 13279-13287Gulcin, I., Antioxidant and antiradical activities of L-carnitine (2006) Life Sci, 78, pp. 803-811Itagaki, M., Takaguri, A., Kano, S., Kaneta, S., Ichihara, K., Satoh, K., Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats (2009) J. Pharmacol. Sci., 109, pp. 94-101Kaikkonen, J., Tuomainen, T.P., Nyyssonen, K., Salonen, J.T., Coenzyme Q10 absorption, antioxidative properties, determinants, and plasma levels (2002) Free Radic. Res, 36, pp. 389-397Kaufmann, P., Torok, M., Zahno, A., Waldhauser, K.M., Brecht, K., Krahenbuhl, S., Toxicity of statins on rat skeletal muscle mitochondria (2006) Cell. Mol. Life Sci., 63, pp. 2415-2425Keil, U., Scherping, I., Hauptmann, S., Schuessel, K., Eckert, A., Muller, W.E., Piracetam improves mitochondrial dysfunction following oxidative stress (2006) Br. J. Pharmacol., 147, pp. 199-208Kettawan, A., Takahashi, T., Kongkachuichai, R., Charoenkiatkul, S., Kishi, T., Okamoto, T., Protective effects of coenzyme q(10) on decreased oxidative stress resistance induced by simvastatin (2007) J. Clin. Biochem. Nutr., 40, pp. 194-202Kumaran, S., Savitha, S., Anusuya Devi, M., Panneerselvam, C., L-carnitine and DL-alpha-lipoic acid reverse the age-related deficit in glutathione redox state in skeletal muscle and heart tissues (2004) Mech. Ageing Dev., 125, pp. 507-512Kumaran, S., Subathra, M., Balu, M., Panneerselvam, C., Supplementation of L-carnitine improves mitochondrial enzymes in heart and skeletal muscle of aged rats (2005) Exp. Aging Res., 31, pp. 55-67Kuznetsov, A.V., Veksler, V., Gellerich, F.N., Saks, V., Margreiter, R., Kunz, W.S., Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells (2008) Nat. Protoc., 3, pp. 965-976Kwak, H.B., Thalacker-Mercer, A., Anderson, E.J., Lin, C.T., Kane, D.A., Lee, N.S., Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes (2012) Free Radic. Biol. Med., 52, pp. 198-207Laaksonen, R., Jokelainen, K., Sahi, T., Tikkanen, M.J., Himberg, J.J., Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans (1995) Clin. Pharmacol. Ther., 57, pp. 62-66Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels (1998) N. Engl. J. Med., 339, pp. 1349-1357. , LIPID (The Long-Term Intervention with Pravastatin in Ischaemic Disease) Study GroupLittarru, G.P., Langsjoen, P., Coenzyme Q10 and statins: biochemical and clinical implications (2007) Mitochondrion, 7 (SUPPL.), pp. S168-S174Littarru, G.P., Tiano, L., Clinical aspects of coenzyme Q10 an update (2010) Nutrition, 26, pp. 250-254Mabuchi, H., Nohara, A., Kobayashi, J., Kawashiri, M.A., Katsuda, S., Inazu, A., Effects of CoQ10 supplementation on plasma lipoprotein lipid (2007) CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis, 195, pp. e182-e189Mescka, C., Moraes, T., Rosa, A., Mazzola, P., Piccoli, B., Jacques, C., In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease (2011) Metab. Brain Dis., 26, pp. 21-28Miyake, Y., Shouzu, A., Nishikawa, M., Yonemoto, T., Shimizu, H., Omoto, S., Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients (1999) Arzneimittelforschung, 49, pp. 324-329Moretti, S., Famularo, G., Marcellini, S., Boschini, A., Santini, G., Trinchieri, V., L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine (2002) Antioxid. Redox Signal., 4, pp. 391-403Munnich, A., Rustin, P., Rotig, A., Chretien, D., Bonnefont, J.P., Nuttin, C., Clinical aspects of mitochondrial disorders (1992) J. Inherit. Metab. Dis., 15, pp. 448-455Nadanaciva, S., Dykens, J.A., Bernal, A., Capaldi, R.A., Will, Y., Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration (2007) Toxicol. Appl. Pharmacol., 223, pp. 277-287Naini, A., Lewis, V.J., Hirano, M., Dimauro, S., Primary coenzyme Q10 deficiency and the brain (2003) Biofactors, 18, pp. 145-152Oliveira, K.A., Zecchin, K.G., Alberici, L.C., Castilho, R.F., Vercesi, A.E., Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction (2008) J. Bioenerg. Biomembr., 40, pp. 307-314Paiva, H., Thelen, K.M., Van Coster, R., Smet, J., De Paepe, B., Mattila, K.M., High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial (2005) Clin. Pharmacol. Ther., 78, pp. 60-68Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., Greenamyre, J.T., Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication (2005) J. Biol. Chem., 280, pp. 42026-42035Radi, R., Rodriguez, M., Castro, L., Telleri, R., Inhibition of mitochondrial electron transport by peroxynitrite (1994) Arch. Biochem. Biophys., 308, pp. 89-95Redfearn, E.R., Whittaker, P.A., The determination of the oxidation-reduction states of ubiquinone (coenzyme Q) in rat-liver mitochondria (1966) Biochim. Biophys. Acta, 118, pp. 413-418Robinson, B.H., Lacticacidemia. Biochemical, clinical, and genetic considerations (1989) Adv. Hum. Genet, 18, pp. 151-179. , 371-372Rundek, T., Naini, A., Sacco, R., Coates, K., Dimauro, S., Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke (2004) Arch. Neurol., 61, pp. 889-892Sacher, J., Weigl, L., Werner, M., Szegedi, C., Hohenegger, M., Delineation of myotoxicity induced by 3-hydroxy-3-methylglutaryl CoA reductase inhibitors in human skeletal muscle cells (2005) J. Pharmacol. Exp. Ther., 314, pp. 1032-1041Sener, G., Paskaloglu, K., Satiroglu, H., Alican, I., Kacmaz, A., Sakarcan, A., L-carnitine ameliorates oxidative damage due to chronic renal failure in rats (2004) J. Cardiovasc. Pharmacol., 43, pp. 698-705Shen, W., Liu, K., Tian, C., Yang, L., Li, X., Ren, J., Protective effects of R-alpha-lipoic acid and acetyl-L-carnitine in MIN6 and isolated rat islet cells chronically exposed to oleic acid (2008) J. Cell. Biochem., 104, pp. 1232-1243Shepherd, D., Garland, P.B., The kinetic properties of citrate synthase from rat liver mitochondria (1969) Biochem. J., 114, pp. 597-610Silva-Adaya, D., Perez-De La Cruz, V., Herrera-Mundo, M.N., Mendoza-Macedo, K., Villeda-Hernandez, J., Binienda, Z., Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine (2008) J. Neurochem., 105, pp. 677-689Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Simvastatin induces impairment in skeletal muscle while heart is protected (2005) Biochem. Biophys. Res. Commun., 338, pp. 1426-1434Sirvent, P., Mercier, J., Vassort, G., Lacampagne, A., Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle (2005) Biochem. Biophys. Res. Commun., 329, pp. 1067-1075Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins (2012) Toxicol. Appl. Pharmacol., 259, pp. 263-268Sirvent, P., Mercier, J., Lacampagne, A., New insights into mechanisms of statin-associated myotoxicity (2008) Curr. Opin. Pharmacol., 8, pp. 333-338Skottheim, I.B., Gedde-Dahl, A., Hejazifar, S., Hoel, K., Asberg, A., Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro (2008) Eur. J. Pharm. Sci., 33, pp. 317-325Thibault, A., Samid, D., Tompkins, A.C., Figg, W.D., Cooper, M.R., Hohl, R.J., Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer (1996) Clin. Cancer Res, 2, pp. 483-491Tobert, J.A., Hitzenberger, G., Kukovetz, W.R., Holmes, I.B., Jones, K.H., Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase (1982) Atherosclerosis, 41, pp. 61-65Vamos, E., Voros, K., Vecsei, L., Klivenyi, P., Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease (2010) Biomed. Pharmacother., 64, pp. 282-286Velho, J.A., Okanobo, H., Degasperi, G.R., Matsumoto, M.Y., Alberici, L.C., Cosso, R.G., Statins induce calcium-dependent mitochondrial permeability transition (2006) Toxicology, 219, pp. 124-132Venero, C.V., Thompson, P.D., Managing statin myopathy (2009) Endocrinol. Metab. Clin. North Am., 38, pp. 121-136Virmani, A., Gaetani, F., Binienda, Z., Xu, A., Duhart, H., Ali, S.F., Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine (2004) Ann. N. Y. Acad. Sci., 1025, pp. 267-273Yapar, K., Kart, A., Karapehlivan, M., Atakisi, O., Tunca, R., Erginsoy, S., Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice (2007) Exp. Toxicol. Pathol., 59, pp. 121-128Yasuda, N., Matzno, S., Iwano, C., Nishikata, M., Matsuyama, K., Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry (2005) J. Pharm. Biomed. Anal., 39, pp. 712-717Ye, J., Li, J., Yu, Y., Wei, Q., Deng, W., Yu, L., L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway (2010) Regul. Pept., 161, pp. 58-66Young, J.M., Molyneux, S.L., Reinheimer, A.M., Florkowski, C.M., Frampton, C.M., Scott, R.S., Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy (2011) Atherosclerosis, 218, pp. 188-193Zhang, Z., Zhao, M., Wang, J., Ding, Y., Dai, X., Li, Y., Effect of acetyl-L-carnitine on the insulin resistance of L6 cells induced by tumor necrosis factor-alpha (2010) Wei Sheng Yan Jiu, 39, pp. 152-15